OXALIPLATIN INTAS oxaliplatin 50 mg/10 mL concentrated injection vial

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

oxaliplatin, Quantity: 50 mg

MAH:

Accord Healthcare Pty Ltd

INN:

Oxaliplatin

pharmaceutical_form:

Injection, concentrated

composition:

Excipient Ingredients: water for injections; lactose monohydrate

administration_route:

Intravenous Infusion

units_in_package:

1 vial

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: Adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour; Treatment of advanced colorectal cancer.

leaflet_short:

Visual Identification: A clear, colourless solution in a clear glass vial. When examined under suitable conditions of visibility it should be practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Registered

authorization_date:

2014-10-09